Louisiana 2016 Regular Session

Louisiana Senate Bill SB271

Introduced
3/4/16  
Introduced
3/4/16  
Refer
3/4/16  
Refer
3/4/16  
Refer
3/14/16  
Refer
3/14/16  
Report Pass
4/13/16  
Report Pass
4/13/16  
Engrossed
4/21/16  
Refer
4/25/16  
Refer
4/25/16  
Report Pass
5/3/16  
Report Pass
5/3/16  
Enrolled
5/17/16  
Enrolled
5/17/16  
Chaptered
5/19/16  
Chaptered
5/19/16  
Passed
5/19/16  

Caption

Provides for medical marijuana. (See Act) (RE1 SEE FISC NOTE GF EX See Note)

Impact

SB271 significantly modifies existing Louisiana laws related to medical marijuana by formalizing the process through which physicians can recommend its use. It institutes strict regulations and oversight mechanisms for the production and dispensing of medical marijuana, ensuring that products meet safety and quality standards. The bill provides a clear structure for licensure, requiring potential dispensers to demonstrate financial capability and maintain rigorous operational standards. This will likely lead to an increase in the availability of medical marijuana for patients who require therapeutic interventions.

Summary

Senate Bill 271 aims to establish a regulatory framework for the prescription and dispensing of medical marijuana in Louisiana. The bill allows licensed physicians to recommend marijuana for therapeutic use to patients with designated debilitating medical conditions, such as cancer and seizure disorders. The legislation outlines the responsibilities of various state agencies, including the Louisiana Board of Pharmacy and the Department of Agriculture and Forestry, in overseeing the production, distribution, and regulation of medical marijuana within the state.

Sentiment

The general sentiment around SB271 appears to be supportive among medical professionals, patient advocacy groups, and some lawmakers who emphasize the need for legitimate access to medical marijuana. However, there are concerns regarding regulatory burdens on dispensers and the pharmaceutical quality of the products. Overall, the discourse suggests a balance between ensuring patient access to therapeutic options while maintaining safety and accountability in the distribution process.

Contention

Notable points of contention include the limitations placed on the types of marijuana products that can be prescribed and the regulatory requirements imposed on dispensers and producers. Critics express concerns that these regulations may hinder patient access in practical terms, while proponents argue that such regulations are necessary to ensure the safe and effective use of medical marijuana. Additionally, the provisions regarding criminal background checks for applicants seeking licensure have raised discussions about the implications for potential dispensers.

Companion Bills

No companion bills found.

Similar Bills

LA HB627

Authorizes the recommendation of medical marijuana for treating certain health conditions of persons with autism

LA HB568

Provides that the regulation of therapeutic cannabis be placed under the authority of the Louisiana Department of Health (EG DECREASE GF EX See Note)

LA SB143

Enacts Alison Neustrom Act and provides relative to prescribed marijuana for therapeutic uses and the development of rules and regulations by the Louisiana Board of Pharmacy and the Louisiana State Board of Medical Examiners. (gov sig)

LA HB720

Authorizes the use of medical marijuana in Louisiana

LA SB541

Provides for the use of marijuana for medicinal purposes. (8/1/14)

LA HB6

Authorizes the use of medical marijuana in Louisiana

LA HB579

Provides relative to the authorization for therapeutic use of marijuana

LA HB697

Reforms the state systems for regulating the production of marijuana for therapeutic use and for the dispensing of such product (EN INCREASE SG EX See Note)